Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Molnupiravir – An oral treatment for COVID-19 filed for EUA
October 11, 2021 - Merck announced the submission of an application for emergency use authorization (EUA) to the FDA for molnupiravir, an oral treatment for COVID-19.
